Vitargent (International) Biotechnology Ltd. was established in 2010 as a bio-chem testing services provider with award winning, world leading innovative transgenic fish, fish embryo toxicity (FET) test and chemosensing technologies. Vitargent provides an alternative in vivo toxicity screening methods to replace animals testing which is the first company in Asia to introduce such a platform in compliance with European Union Directive. Our alternative in vivo toxicity screening assays designed to improve the safety and support the needs of these industries:
- Personal Care
Vitargent resides in the Biotech Centre of Hong Kong Science & technology Parks (HKSTP), a state-of-the art facility that serves as high technology incubator for new biotech companies in the region. Vitargent is led by an experienced management team with advice from a Scientific Advisory Board of internationally-renowned scientists and thought leaders in the areas of chemosensing technology, polymerase chain reaction (PCR), molecular biology, pathology and toxicology. The team has repeatedly demonstrated the value of early in vivo toxicity data in the Chinese medicine formulations, food safety and cosmetic ingredient review and toxicology risk assessment process.
Vitargent as a Contract Research Organisation (CRO) focused on in vivo toxicity and low cost chemosensing methods screening of both specific and unknown toxic chemicals. We are tirelessly serving some internationally renowned testing organizations such as SGS, Fugro (MateriaLab), CMA, BGI, various inspection and quarantine bureaus and government divisions in Hong Kong and Mainland China.